Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Evotec AG    EVT   DE0005664809

EVOTEC AG (EVT)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about EVOTEC AG
02/19EVOTEC : and MaRS Innovation announce first funded project under LAB150 BRIDGE
AQ
02/15EVOTEC : and MaRS Innovation Announce First Funded Project under LAB150 Bridge
BU
02/15EVOTEC : And mars innovation announce first funded project under lab150 bridge
EQ
01/31EVOTEC AG : Release according to Article 41 of the WpHG [the German Securities T..
EQ
01/19EVOTEC AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
01/08EVOTEC : and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sa..
BU
01/08EVOTEC : And apeiron achieve first milestone in immuno-oncology alliance with sa..
EQ
01/05EVOTEC : to attend upcoming investor conferences
AQ
01/03EVOTEC : to Attend Upcoming Investor Conferences
BU
01/03EVOTEC : to attend upcoming investor conferences
PU
01/03EVOTEC : To attend upcoming investor conferences
EQ
2017EVOTEC AG : Release according to Article 26, Section 1 of the WpHG [the German S..
EQ
2017EVOTEC AG : Release according to Article 26, Section 1 of the WpHG [the German S..
EQ
2017EVOTEC AG : Release according to Article 26, Section 1 of the WpHG [the German S..
EQ
2017EVOTEC AG : Release according to Article 26a of the WpHG [the German Securities ..
EQ
More most relevant news
All news about EVOTEC AG
02/23EVOTEC : and MaRS Innovation Announce First Funded Project under LAB150 Bridge
AQ
02/19EVOTEC : and MaRS Innovation announce first funded project under LAB150 BRIDGE
AQ
02/15EVOTEC : and MaRS Innovation Announce First Funded Project under LAB150 Bridge
BU
02/15EVOTEC : And mars innovation announce first funded project under lab150 bridge
EQ
01/31EVOTEC AG : Release according to Article 41 of the WpHG [the German Securities T..
EQ
01/19EVOTEC AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
01/10EVOTEC : Apeiron, Evotec to get 3 mn milestone payment from Sanofi in immuno-onc..
AQ
01/08EVOTEC : and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sa..
BU
01/08EVOTEC : And apeiron achieve first milestone in immuno-oncology alliance with sa..
EQ
01/05EVOTEC : to attend upcoming investor conferences
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
02/23SANOFI : Says U.S. Waiting Period for Bioverativ Has Expired
DJ
02/22SANGAMO THERAPEUTICS : Surges on Therapy Collaboration Deal with Kite -- Market ..
DJ
02/22Sangamo in $3 billion gene-editing deal with Gilead
RE
02/15French pharma group Ipsen sees more asset purchases, U.S. growth
RE
02/15Oxford BioMedica wins second $100 million gene therapy contract
RE
02/14Bristol-Myers to pay $1.85 billion in cancer deal with Nektar
RE
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
2017Evotec enters into research collaboration with CRTD to discover therapies for.. 
2017Evotec (EVTCY) Presents At Jefferies 2017 London Healthcare Conference - Slid.. 
2017Evotec's (EVOTF) CEO Werner Lanthaler on Q3 2017 Results - Earnings Call Tran.. 
2017MY JOURNEY TO FINANCIAL INDEPENDENCE : 85-Stock October Portfolio Update - Buyin.. 
2017Evotec AG ADR 2017 Q3 - Results - Earnings Call Slides 
2017Evotec AG reports Q3 results 
Latest Tweets
02/21Evotec – so sind 100 Prozent bis Juni drin  
02/15EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRID.. 
02/15EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRID.. 
02/15Evotec and MaRS Innovation Announce First Funded Project under LAB150 Bridge .. 
02/15Evotec and MaRS Innovation Announce First Funded Project under LAB150 Bridge:.. 
More tweets
Qtime:185
Financials (€)
Sales 2017 248 M
EBIT 2017 41,6 M
Net income 2017 32,5 M
Debt 2017 97,5 M
Yield 2017 -
P/E ratio 2017 64,82
P/E ratio 2018 47,46
EV / Sales 2017 9,35x
EV / Sales 2018 7,22x
Capitalization 2 224 M
Chart EVOTEC AG
Duration : Period :
Evotec AG Technical Analysis Chart | EVT | DE0005664809 | 4-Traders
Technical analysis trends EVOTEC AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 19,0 €
Spread / Average Target 26%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Mario Polywka Chief Operating Officer
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC AG8.96%2 734
CELLTRION, INC.--.--%35 080
IQVIA HOLDINGS INC0.49%20 749
LONZA GROUP-6.95%19 560
INCYTE CORPORATION-10.05%17 877
NEKTAR THERAPEUTICS47.71%13 613